(Q40088394)

English

ACTH and neuromuscular transmission: Electrophysiological in vitro investigation of the effects of corticotropin and an ACTH fragment on neuromuscular transmission

scientific article published on March 1, 1977

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ACTH and neuromuscular transmission: Electrophysiological in vitro investigation of the effects of corticotropin and an ACTH fragment on neuromuscular transmission (English)

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

author name string

K. L. Birnberger

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196543

29 December 2022

R. Rüdel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196543

29 December 2022

A. Struppler

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196543

29 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=196543

29 December 2022

publication date

1 March 1977

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

full work available at URL

http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410010313

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410010313

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410010313

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

270-275

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

The active sequence in the ACTH molecule responsible for inhibition of the extinction of conditioned avoidance behaviour in rats

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

Antibiotic blockade of neuromuscular function

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

3

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Treatment of severe myasthenia gravis with large doses of ACTH

5

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Corticotropin therapy in myasthenia gravis: effects, indications, and limitations

6

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy

7

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Benefit from alternate-day prednisone in myasthenia gravis

8

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The treatment of severe myasthenia gravis with immunosuppressive agents

9

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Changes in serum complement activity in patients with myasthenia gravis

11

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors

12

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Autoimmune Response to Acetylcholine Receptor

13

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Glucocorticoids and Mammalian Motor Nerve Excitability

15

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Corticosteroids: a direct effect at the neuromuscular junction

16

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Effect of pituitary hormones, cortisone and adrenalectomy on some aspects of neuromuscular function and acetylcholine synthesis

17

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

A possible direct action of ACTH on nerve and muscle

18

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

A Modulatory Effect of Pituitary Polypeptides on Peripheral Nerve and Muscle

20

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The quantal components of the mammalian end-plate potential

23

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

On the factors which determine the amplitude of the miniature end-plate potential

24

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Mechanism of Colistin-Induced Neuromuscular Depression

25

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The end-plate potential in mammalian muscle

26

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Effects of catecholamines on the neuromuscular junction in the rat diaphragm

27

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Ionic dependence of adrenal steroidogenesis and ACTH-induced changes in the membrane potential of adrenocortical cells

28

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Cell membrane permeability change: an important step in hormone action

29

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The effects of depolarization of motor nerve terminals upon the release of transmitter by nerve impulses

30

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Presynaptic failure of neuromuscular propagation in rats

31

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Myasthenic Syndrome Associated With Antibiotics

33

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Depolarization and calcium entry in squid giant axons

35

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The effect of calcium and magnesium on the spontaneous release of transmitter from mammalian motor nerve endings

36

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.

37

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Radioimmunoassay of ACTH in plasma

38

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Myasthenia gravis and acetylcholine receptor. Effect of steroids in clinical course and cellular immune response to acetylcholine receptor

39

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Identifiers

10.1002/ANA.410010313

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40088394&oldid=1797687768"